Sandeep Athalye MBBS, MD

Dr. Sandeep Athalye is the Head of Clinical Development & Medical Affairs at Biocon Biologics. After a stint with Biocon early in his career, Sandeep joined back the organization in 2017 as Chief Medical Officer and has since been responsible for Clinical Development & Operations, Pharmacovigilance & Drug Safety, and Medical Affairs. He assumed his current role in 2019.

He has over 20 years of experience in Clinical Development and Medical Affairs spanning the US, Europe, and Asia. Sandeep spent 12 years in the US with Schering Plough and Novartis, where he was responsible for the global development of assets across several therapeutic areas. He then led the clinical development team at Biocon, before taking up a leadership role at Boehringer Ingelheim in Germany in the Biosimilars Unit. He also has experience in setting up development operations in China. Sandeep has done a mini MBA in BioPharma Innovation at the Rutgers University, New Brunswick, US; an MS in Clinical Pharmacology at the University of Toledo, US, and an MBBS in Medicine at the Bharati Vidyapeeth, India.